Researchers at Charité Berlin Identify Novel Therapeutic Target to Halt Chronic Inflammatory Bowel Disease and Reduce Cancer Risk
Chronic inflammatory bowel diseases (IBD) represent some of the most persistent and debilitating challenges in modern gastroenterology. Characterized by a relentless cycle of inflammation,...
